tibet rhodiola pharm-a
(600211:Shanghai Stock Exchange)
Transactions by TIBET RHODIOLA PHARM-A (600211) in the last 6 months
Dingzhong agreed to acquire an additional 51% stake in Sichuan Bencaotang Pharmaceutical Co., Ltd from Tibet Rhodiola Pharmaceutical Holding Company (SHSE:600211) for CNY 41.3 million in cash on July 28, 2015. Sichuan Bencaotang Pharmaceutical reported total assets of CNY 372.3 million, total owner’s equity of CNY 25.5 million, revenue of CNY 1.2 billion and net profit of CNY 0.12 million for the year ending December 31, 2014. The transaction is subject to approval from ...
|No competitor information is available for 600211.|
|View Industry Companies|